← All diseases Brain and nervous system

Multiple sclerosis (progressive)

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchEvidence of the highest level only (104)Meta-analysis (24)Treatment guideline (1)Randomized trial (43)Systematic review (21)Phase 3 Study (15)Clinical trial (370)Review article (234)Early study (phase 1 or 2) (22)Case report (83)Laboratory or animal study (21)Commentary or editorial (19) Studies currently recruiting participants only (33)

Filter

Publications and studies (1543)

• Myelin imaging measures as predictors of cognitive impairment in MS patients: A hybrid PET-MRI study. (2022/01/01) ♡
• Understanding the role of the blood brain barrier and peripheral inflammation on behavior and pathology on ongoing confined cortical lesions. (2022/01/01) ♡
• Diagnosis of Alzheimer's disease and related dementia among people with multiple sclerosis: Large cohort study, USA. (2022/01/01) ♡
• Serum neurofilament light chain correlates with myelin and axonal magnetic resonance imaging markers in multiple sclerosis. (2022/01/01) ♡
• A web-based life-style, exercise and activity intervention for people with progressive multiple sclerosis: Results of a single-arm feasibility study. (2022/01/01) ♡
• Progressive Multifocal Leukoencephalopathy Risk Perception in Patients Considering Natalizumab for Multiple Sclerosis. (2022/01/01) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Effectiveness of non-pharmacological rehabilitation interventions in pain management in patients with multiple sclerosis: Systematic review and meta-analysis. (2022/01/01) ♡
• Complementary and alternative medicine in multiple sclerosis: a questionnaire-based study. (2022/01/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Guanidinoacetate-creatine in secondary progressive multiple sclerosis: a case report. (2022/01/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Evaluation of Safety, Tolerability and Preliminary Efficacy of EHP-101 in Relapsing Forms of Multiple Sclerosis (2022-10-21) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Transient and Immediate Motor Effects of Exercise in Progressive Multiple Sclerosis (2022-10-14) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Imaging of Intracerebral Inflammation in MS (2022-09-16) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The Influence of HIIT Versus MCT on Cardiorespiratory Fitness in PPMS (2022-06-14) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. MUSCLE - Nordic Walking in MUltiple SCLErosis (2022-05-23) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Hydroxychloroquine and Indapamide in SPMS (2022-05-18) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Long-term Follow-up Study Of Multiple Sclerosis Patients Who Participated In Genzyme-sponsored Studies of GZ402668 (2022-05-12) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Exercise on Contactin-1 and Contactin-2 Level in Persons With Multiple Sclerosis (2022-04-28) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple Sclerosis (2022-04-25) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Follow-up Study of the Effectiveness of Virtual Reality Therapy in MS Patients (2022-04-05) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Automated EDSS Score Calculation by Smartphone Application (2022-03-18) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Phase 2 Clinical Study in Subjects With Primary Progressive Multiple Sclerosis to Assess the Efficacy, Safety and Tolerability of Two Oral Doses of Laquinimod Either of 0.6 mg/Day or 1.5mg/Day (Experimental Drug) as Compared to Placebo (2022-03-10) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Pilot Trial of Remotely-Supervised Transcranial Direct Current Stimulation (RS-tDCS) to Enhance Motor Learning in Progressive Multiple Sclerosis (MS) (2022-03-09) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Phase 1b Multiple Ascending Dose Study of Foralumab in Primary and Secondary Progressive MS (2022-03-03) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. G-EO Gait Rehabilitation Training in Progressive Multiple Sclerosis (2022-02-14) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Measuring Active Microglia in Progressive Multiple Sclerosis (2022-01-18) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Prospective Biomarker Study in Active SPMS Subjects Treated With Cladribine Tablets (2022-01-13) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. New Promising Therapeutic Avenues of Curcumin in Brain Diseases. (2021/12/31) ♡
• Memory in Polish multiple sclerosis patients - correlations with mood and fatigue. (2021/12/31) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cognitive Rehabilitation in Multiple Sclerosis in the Period from 2013 and 2021: A Narrative Review. (2021/12/30) ♡
• Prevalence of Anxiety and Depression in Patients With Multiple Sclerosis in Saudi Arabia: A Cross-Sectional Study. (2021/12/29) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Mimicking Amyotrophic Lateral Sclerosis: A Case of a Spinal Dural Arteriovenous Fistula. (2021/12/27) ♡
• Evaluation of the expressed miR-129 and miR-549a in patients with multiple sclerosis. (2021/12/25) ♡
• Comparative Proteomic Profiling Identifies Reciprocal Expression of Mitochondrial Proteins Between White and Gray Matter Lesions From Multiple Sclerosis Brains. (2021/12/24) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Therapeutic Application of rTMS in Atypical Parkinsonian Disorders. (2021/12/23) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Proteinopathies as Hallmarks of Impaired Gene Expression, Proteostasis and Mitochondrial Function in Amyotrophic Lateral Sclerosis. (2021/12/23) ♡
• Phenotyping of multiple sclerosis lesions according to innate immune cell activation using 18 kDa translocator protein-PET. (2021/12/22) ♡
• Iron Rims in Patients With Multiple Sclerosis as Neurodegenerative Marker? A 7-Tesla Magnetic Resonance Study. (2021/12/21) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Paratuberculosis: The Hidden Killer of Small Ruminants. (2021/12/21) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Primary Progressive Multiple Sclerosis in a Portuguese Patient With Neurofibromatosis Type 1. (2021/12/21) ♡
• The results of a 24-month controlled, prospective study of relapsing multiple sclerosis patients at risk for progressive multifocal encephalopathy, who switched from prolonged use of natalizumab to teriflunomide. (2021/12/16) ♡
• NK Cells and Innate-Like T Cells After Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis. (2021/12/16) ♡
• Treating sarcoidosis-associated progressive multifocal leukoencephalopathy with infliximab. (2021/12/16) ♡
• Fatigue, Physical Disability and Self-Efficacy as Predictors of the Acceptance of Illness and Health-Related Quality of Life in Patients with Multiple Sclerosis. (2021/12/15) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Emerging Mechanisms Underpinning Neurophysiological Impairments in C9ORF72 Repeat Expansion-Mediated Amyotrophic Lateral Sclerosis/Frontotemporal Dementia. (2021/12/15) ♡
• Altered Plasma Metabolic Profiles in Chinese Patients With Multiple Sclerosis. (2021/12/15) ♡
• Feasibility of cognitive rehabilitation in patients with advanced multiple sclerosis: A pilot study. (2021/12/10) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Efficacy of Virtual Reality and Exergaming in Improving Balance in Patients With Multiple Sclerosis: A Systematic Review and Meta-Analysis. (2021/12/10) ♡
• Correlates of Objectively Measured Physical Activity Among People With Multiple Sclerosis: A Cross-Sectional Study. (2021/12/10) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Prevalence and burden of multiple sclerosis-related fatigue: a systematic literature review. (2021/12/02) ♡
• Experiences in treatment of multiple sclerosis with natalizumab from a real-life cohort over 15 years. (2021/12/02) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.